Molecular-Genetic Imaging of Cancer

被引：16
作者：
Minn, Il [1 ]
Menezes, Mitchell E. [2 ]
Sarkar, Siddik [2 ]
Yarlagadda, Keerthi [1 ]
Das, Swadesh K. [2 ,3 ]
Emdad, Luni [2 ,3 ,4 ]
Sarkar, Devanand [2 ,3 ,4 ]
Fisher, Paul B. [2 ,3 ,4 ]
Pomper, Martin G. [1 ,5 ]
机构：
[1] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA
[2] Dept Human & Mol Genet, Richmond, VA USA
[3] Virginia Commonwealth Univ, Sch Med, VCU Inst Mol Med, Richmond, VA USA
[4] Virginia Commonwealth Univ, Sch Med, VCU Massey Canc Ctr, Richmond, VA USA
[5] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
EMERGING APPLICATIONS OF MOLECULAR IMAGING TO ONCOLOGY | 2014年 / 124卷
关键词：
2-STEP TRANSCRIPTIONAL AMPLIFICATION; IN-VIVO; MEMBRANE ANTIGEN; PLASMID DNA; TRANSGENE EXPRESSION; REPORTER GENE; PAMAM DENDRIMERS; PROSTATE-CANCER; MESSENGER-RNA; INTRAMUSCULAR INJECTION;
D O I：
10.1016/B978-0-12-411638-2.00004-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Molecular-genetic imaging of cancer using nonviral delivery systems has great potential for clinical application as a safe, efficient, noninvasive tool for visualization of various cellular processes including detection of cancer, and its attendant metastases. In recent years, significant effort has been expended in overcoming technical hurdles to enable clinical adoption of molecular-genetic imaging. This chapter will provide an introduction to the components of molecular-genetic imaging and recent advances on each component leading to safe, efficient clinical applications for detecting cancer. Combination with therapy, namely, generating molecular-genetic theranostic constructs, will provide further impetus for clinical translation of this promising technology.
引用
收藏
页码：131 / 169
页数：39
相关论文
共 50 条
[41]   Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy [J].
Fontana, Fabrizio ;
Anselmi, Martina ;
Limonta, Patrizia .
CANCER LETTERS, 2022, 534
[42]   Molecular genetic aspects of prostate cancer radioresistance [J].
Omelchuk, E. P. ;
Kutilin, D. S. ;
Dimitriadi, S. N. ;
Gusareva, M. A. ;
Timoshkina, N. N. .
BYULLETEN SIBIRSKOY MEDITSINY, 2021, 20 (03) :182-192
[43]   Molecular and genetic prognostic factors of prostate cancer [J].
Chakravarti, A ;
Zhai, GG .
WORLD JOURNAL OF UROLOGY, 2003, 21 (04) :265-274
[44]   Molecular genetic markers in diagnosis of lung cancer [J].
Ponomaryova, A. A. ;
Rykova, E. Yu. ;
Cherdyntseva, N. V. ;
Choinzonov, E. L. ;
Laktionov, P. P. ;
Vlassov, V. V. .
MOLECULAR BIOLOGY, 2011, 45 (02) :175-189
[45]   Molecular and genetic prognostic factors of prostate cancer [J].
Arnab Chakravarti ;
Gary Guotang Zhai .
World Journal of Urology, 2003, 21 :265-274
[46]   Nuclear Imaging of Cancer Cell Therapies [J].
Ponomarev, Vladimir .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (07) :1013-1016
[47]   Protein-Based MRI Contrast Agents for Molecular Imaging of Prostate Cancer [J].
Wei, Lixia ;
Li, Shunyi ;
Yang, Jianhua ;
Ye, Yiming ;
Zou, Jin ;
Wang, Liya ;
Long, Robert ;
Zurkiya, Omar ;
Zhao, Tiejun ;
Johnson, Julian ;
Qiao, Jingjuan ;
Zhou, Wangda ;
Castiblanco, Adriana ;
Maor, Natalie ;
Chen, Yanyi ;
Mao, Hui ;
Hu, Xiaoping ;
Yang, Jenny J. ;
Liu, Zhi-Ren .
MOLECULAR IMAGING AND BIOLOGY, 2011, 13 (03) :416-423
[48]   The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis [J].
Chowdhury, R. ;
Ganeshan, B. ;
Irshad, S. ;
Lawler, K. ;
Eisenblaetter, M. ;
Milewicz, H. ;
Rodriguez-Justo, M. ;
Miles, K. ;
Ellis, P. ;
Groves, A. ;
Punwani, S. ;
Ng, T. .
BRITISH JOURNAL OF RADIOLOGY, 2014, 87 (1038)
[49]   Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies [J].
van der Meel, Roy ;
Gallagher, William M. ;
Oliveira, Sabrina ;
O'Connor, Aisling E. ;
Schiffelers, Raymond M. ;
Byrne, Annette T. .
DRUG DISCOVERY TODAY, 2010, 15 (3-4) :102-114
[50]   Molecular Imaging of Cancer with Radiolabeled Peptides and PET [J].
Vavere, Amy L. ;
Rossin, Raffaella .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (05) :462-475
12345